A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness
Laurence Corash(Cerus (United States)), Albert Kwok Wai Lie(Queen Mary Hospital), Richard J. Benjamin(Cerus (United States)), Cheuk Kwong Lee(World Health Organization Regional Office for South-East Asia), Wai‐Chiu Tsoi(Chinese University of Hong Kong), Hans Vermeij(Cerus (United States)), Yingjie Liu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Clarence Lam(Queen Mary Hospital), Joycelyn Sim(Queen Mary Hospital), Norman Huang(Cerus (United States)), Rock Y. Y. Leung(Queen Mary Hospital), Adonis Stassinopoulos(Cerus (United States))
Cited by 0
Related Papers
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
|The Lancet Infectious Diseases|2021|251
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
|Clinical Infectious Diseases|2010|193
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009
|Vox Sanguinis|2011|191